| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $211.0M | -35.4% |
| Cost of Revenue | $70.1M | +21.7% |
| R&D Expense | $199.4M | -45.1% |
| SG&A Expense | $198.5M | +17.0% |
| Operating Income | -$256.9M | +2.6% |
| Interest Expense | $32.5M | +41.4% |
| Pre-tax Income | -$291.8M | -1.6% |
| Income Tax | $0 | — |
| Net Income | -$291.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $63.5M | -84.8% |
| Short-term Investments | $128.1M | — |
| Accounts Receivable | $110.0M | -10.6% |
| Inventory | $38.8M | +3.1% |
| Current Assets | $381.2M | -36.7% |
| Total Assets | $480.8M | -29.2% |
| Current Liabilities | $138.7M | -16.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$241.1M | -544.2% |
| Capital Expenditures | $2.0M | +58.2% |
| Investing Cash Flow | -$166.8M | -20.5% |
| Financing Cash Flow | $54.3M | +4.7% |
| Free Cash Flow | -$243.2M | -528.0% |
| -1.6% |
| EPS (Basic) | -$3.76 | +1.3% |
| EPS (Diluted) | -$3.76 | +1.3% |
| Total Liabilities |
| $618.3M |
| +6.3% |
| Stockholders' Equity | -$137.4M | -240.6% |